PHARMAZEUTISCHE ENTWICKLUNG

Patent europeic · EP4003293 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4003293
Numer da la dumonda
EP20751254
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-07-2020
Publitgà
01-06-2022
Concedì
04-06-2025
La protecziun finescha il pli tard
27-07-2040
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
A61K 9/00 (2006.01)
A61K 9/19 (2006.01)
A61K 31/7072 (2006.01)
A61K 38/12 (2006.01)
Prioritad
GB 201910787 29.07.2019
Dumonda PCT
PCT/GB2020/051810 28.07.2020
Publicaziun PCT
WO2021/019234 04.02.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-04-2026

    Midada

    Published in Swissreg on 16.04.2026

  2. 08-08-2025

    Midada

    Published in Swissreg on 08.08.2025

  3. 04-08-2025

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 04.08.2025

  4. 04-06-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Partidas

Possessur

Helperby Therapeutics Limited

66 Lincoln's Inn Fields, London, Greater London WC2A 3LH, GB

Represchentant

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventur

COATES, Professor Anthony

London Greater London SW17 0RE, GB

HU, Yanmin

London Greater London SW17 0RE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.